Ha-Won Jeong

Title: Ha-Won Jeong: Innovator in Peptide Research

Introduction

Ha-Won Jeong is a prominent inventor based in Daegu, South Korea. He has made significant contributions to the field of peptide research, particularly in relation to endothelial cells. His innovative work focuses on the use of peptides that interact with specific integrins, which play a crucial role in various biological processes.

Latest Patents

Ha-Won Jeong holds 1 patent for his invention titled "Use of a peptide that interacts with αvβ3 integrin of endothelial cell." This patent describes a method for inhibiting endothelial cell adhesion, migration, and angiogenesis using a peptide consisting of at least 18 amino acids. The peptide includes tyrosine-histidine (TY) or asparagines-histidine (NH), along with at least three hydrophobic amino acids with bulky side chains. Furthermore, the invention provides a method for treating or preventing diseases related to angiogenesis.

Career Highlights

Ha-Won Jeong is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work at this institution has allowed him to explore innovative solutions in the field of biomedical research. His research has the potential to impact various medical applications, particularly in treating diseases associated with angiogenesis.

Collaborations

Ha-Won Jeong has collaborated with notable colleagues, including Ju-Ock Nam and Jung-Eun Kim. These collaborations have contributed to the advancement of research in peptide interactions and their implications in medical science.

Conclusion

Ha-Won Jeong is a dedicated inventor whose work in peptide research holds promise for future medical advancements. His innovative approaches to understanding endothelial cell behavior may lead to significant breakthroughs in treating angiogenesis-related diseases.